| For: | Leowattana W, Leowattana T. Chronic hepatitis B: New potential therapeutic drugs target. World J Virol 2022; 11(1): 57-72 [PMID: 35117971 DOI: 10.5501/wjv.v11.i1.57] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i1/57.htm |
| Number | Citing Articles |
| 1 |
Yasunari Matsuzaka, Ryu Yashiro. In Silico Protein Structure Analysis for SARS-CoV-2 Vaccines Using Deep Learning. BioMedInformatics 2023; 3(1) doi: 10.3390/biomedinformatics3010004
|
| 2 |
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E. Woodson, Razia Tajwar, John E. Tavis, Grigoris Zoidis. N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules 2024; 29(12) doi: 10.3390/molecules29122942
|
| 3 |
Minh-Cong Hoang, Hong-Quan Duong, Van-Duyet Le, Thi-Thuy-Nga Nguyen, Van-Lang Ngo, The-Hung Dang. Hepatitis B virus genotypes and antiviral drug resistance mutations in treatment-naïve patients with chronic hepatitis B in Bacninh, Vietnam: a cross-sectional study. Therapeutic Advances in Infectious Disease 2025; 12 doi: 10.1177/20499361251344784
|
| 4 |
Jingqi Shi, Qingyu Li, Jian Li, Jian Bai, Ji Xi, Qi He, Jianglin Zhou, Xuejun Wang, Xiang Song, Xiaoju Li, Xiangpei Yue, Xiaochang Zhang, Zhen Sun, Jiangbo Li, Wen Yang, Yuke Cui, Wenjie Shu, Liang Guo, Shengqi Wang. CHB‐Induced Immune Zonation Chaos Elicited LXRα‐mediated Lipid Metabolism Disorders in Kupffer Cells to Induce Cancer Stem Cell Formation. Advanced Science 2026; 13(10) doi: 10.1002/advs.202510275
|
| 5 |
Alla Turshudzhyan, Micheal Tadros. Cautious optimism in anticipation of hepatitis B curative therapies. World Journal of Virology 2022; 11(4): 212-215 doi: 10.5501/wjv.v11.i4.212
|
| 6 |
Lucía Chaves-Blanco, Marta Illescas-López, Ana Fuentes, Raquel Carracedo, Alberto Delgado-Iribarren, Alberto Vázquez Blanquiño, Ana María Blázquez, Ruth Sáez, Ana Miqueleiz, María de los Reyes Vidal, Tomás Tosco, César Gómez, Luz Moldes, Noelia Calvo, Lucía Pérez Rodríguez, Matilde Trigo, María Dolores Ocete, María Jesús Alcaraz, María Asunción Iborra, Julio García, José Joaquín Blas, Aldara María Vallejo, Ana Alberola Romano, Soledad Illescas, Juan Carlos Rodriguez, Roberto Alonso, Margarita Cámara, María Dolores Navarro, María Luisa Núñez, María Jesús del Amor Espín, Alicia Beteta, Eva Cascales, Luis Miguel Soria, Sonsoles Gacinuño, Marta Sandoval, Sandra Cortizo, Patricia Ordóñez, Paloma Liendo, Mercedes Pérez-Ruiz, Marta Álvarez Argüelles, Fernando García, Inmaculada Rodriguez, Carmen Gómez, Luis Elorduy, Melisa Hernández Febles, Alejandro González-Praetorius, Carmen Liébana, María Lourdes Molina, Yolanda Salicio, Mikele Macho, Berta Becerril, Francisco Franco Álvarez, Iker Falces, Sonia Algarate, María José Gude, Daniel Pablo, María Magdalena Lara, Natalia Montiel, Carolina Freyre, Juan Carlos Galán, Ana Belén Pérez, Belén Lorenzo, Pablo Fraile, Waldo Sánchez-Yebra, Isabel Viciana, Antonio Sampedro, María del Carmen Lozano, Ana Domínguez Castaño, Encarnación Ramírez, Inocencio Beltrán, Teresa Martín, Antonio Puerta, Pilar Tajada, Paula Panés, Adrián Martín, Juan Carlos Hurtado, Javier López Braos, Francisco Arjona, Elisenda Miró, Montserrat Ruiz, Mercedes Ramírez, María Gil Fortuño, Rosa González Pellicer, Juan Manuel Acedo, Jorge Anel Pedroche, Ana Infante Urrios, Victoria Domínguez, Guillermo Arán Tohá, Olalla Martínez Macías, Nieves Orta Mira, Luis Torres Sopena, Purificación Cantudo, María Araceli Hernández, Teresa Arroyo Serrano, Ariadna Rando, Marta Garrido, Gema Fernández, Adolfo de Salazar, Antonio Aguilera, Federico García. Implementation of quantitative HBsAg testing in clinical microbiology laboratories in Spain: Results from a national GEHEP-SEIMC survey. Enfermedades Infecciosas y Microbiología Clínica 2026; 44(7) doi: 10.1016/j.eimc.2026.503215
|
| 7 |
Yang Shi, Zihan Wang, Jingjing Xu, Wenxia Niu, Yubin Wu, Huiyu Guo, Jinmiao Shi, Zonglin Li, Baorong Fu, Yunda Hong, Zikang Wang, Wenjie Guo, Dabing Chen, Xingling Li, Qian Li, Shaojuan Wang, Jiahua Gao, Aling Sun, Yaosheng Xiao, Jiali Cao, Lijuan Fu, Yangtao Wu, Tianying Zhang, Ningshao Xia, Quan Yuan. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models. Emerging Microbes & Infections 2024; 13(1) doi: 10.1080/22221751.2024.2387448
|
| 8 |
Rupchand Sutradhar, D.C. Dalal. Exploration of Hepatitis B Virus Infection Dynamics through an Intracellular Model. Journal of Theoretical Biology 2025; 611 doi: 10.1016/j.jtbi.2025.112189
|
| 9 |
Xiaohan Hu, Liwei Zhao, Mingrong Ou, Yuxin Chen, Hongxia Wei, Yanyan Xia, Hongpan Xu, Miao Li, Jun Wang. Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNA. Heliyon 2023; 9(8) doi: 10.1016/j.heliyon.2023.e18557
|
| 10 |
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang. The progress of molecules and strategies for the treatment of HBV infection. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1128807
|
| 11 |
Ernest C. Agwamba, Hitler Louis, Innocent Benjamin, Chioma G. Apebende, Tomsmith O. Unimuke, Henry O. Edet, Akaninyene Udoikono, Adanna D. Nwagu, Adedapo S. Adeyinka. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations. Chemistry Africa 2022; 5(6) doi: 10.1007/s42250-022-00468-4
|
| 12 |
L VANEKOVA, M POLIDAROVA, V CHARVAT, Z VAVRINA, V VEVERKA, G BIRKUS, A BRAZDOVA. Development and Characterization of a Chronic Hepatitis B Murine Model With a Mutation in the START Codon of an HBV Polymerase. Physiological Research 2023; 72(1) doi: 10.33549/physiolres.934979
|
| 13 |
Thu Kim Nguyen, Duyet Van Le. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam. Journal of Global Antimicrobial Resistance 2023; 33 doi: 10.1016/j.jgar.2023.02.013
|
| 14 |
Sajad Ahmad Bhat, Syed Kazim Hasan, Zahoor Ahmad Parray, Zaheenul Islam Siddiqui, Shabnam Ansari, Ayesha Anwer, Saniya Khan, Fatima Amir, Mahboubeh Mehmankhah, Asimul Islam, Zarrin Minuchehr, Syed Naqui Kazim. Potential antiviral activities of chrysin against hepatitis B virus. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00531-6
|
| 15 |
Naveen Kumar, Narendra S. Choudhary. Managing HBV and HCV Infection Pre- and Post-liver Transplant. Journal of Clinical and Experimental Hepatology 2024; 14(2) doi: 10.1016/j.jceh.2023.09.008
|
| 16 |
Qing-Li Yang, Xi-Wei Lu, Zhong-Liao Fang, Yu-Qiu Gao, Yi-Ning He, Yan Huang, Yue Dai, Ming-Yong Liang, Carlos H. F. Chan, Zhi-Hua Jiang. The association between Clonorchis sinensis seropositivity and hepatocellular carcinoma in an endemic area: a study in Guangxi, China. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-10675-2
|
| 17 |
Rupchand Sutradhar, D. C. Dalal. Proceedings of the 2nd International Conference on Nonlinear Dynamics and Applications (ICNDA 2024), Volume 2. Springer Proceedings in Physics 2024; 315 doi: 10.1007/978-3-031-69134-8_3
|
| 18 |
Xiaojiao Li, Jia Xu, Jixuan Sun, Jingrui Liu, Min Wu, Hong Zhang, Xiaoxue Zhu, Cuiyun Li, Yingjun Zhang, Jing Zhu, Yujie Chen, Lin Luo, Qingwei He, Yulei Zhuang, Yunfu Chen, Junqi Niu, Yanhua Ding. Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients. Liver International 2025; 45(1) doi: 10.1111/liv.16213
|
| 19 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7) doi: 10.3390/biomedicines11071944
|
| 20 |
Yimin Chen, Min Deng, Mingkai Tong, Peixia Lin, Hua Xuan, Dahai Wei. A Study on Serum Protein Tracking in Patients with Low Levels of HBsAg Undergoing Treatment for Chronic Hepatitis B with a Combination of Tenofovir Disoproxil Fumarate and Pegylated Interferon. Hepatitis Monthly 2025; 25(1) doi: 10.5812/hepatmon-165660
|
| 21 |
Maria Pfefferkorn, Jessica Brehm, Martin Brehm, Fanny Honshoven, Danilo Deichsel, Laura Vernoux, Vedran Pavlovic, Cynthia Wat, Thomas Berg, Florian van Bömmel. Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application. Virology 2025; 609 doi: 10.1016/j.virol.2025.110576
|
| 22 |
Chengqian Feng, Jingrong Shi, Yunfu Chen, Sisi Chen, Jianping Cui, Jun Zhang, Xiaowen Zheng, Yaping Wang, Feng Li. A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening. Antiviral Research 2025; 237 doi: 10.1016/j.antiviral.2025.106143
|
| 23 |
Chunting Zhu, Jie Yang, Yu Sheng, Min Fang. Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1806527
|
| 24 |
Edward J. Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, William Sievert, Wattana Sukeepaisarnjaroen, Alexander J. Thompson, Vedran Pavlovic, Bernadette Surujbally, Cynthia Wat, Bob D. Brown, Hardean E. Achneck, Man-Fung Yuen. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection. Journal of Hepatology 2023; 79(5) doi: 10.1016/j.jhep.2023.07.026
|